Skip to content
‹ Back to IndustriesHealthcare

Creating Accessibility: Talking Prevention, and Healthcare Access and Innovation

In the latest episode of “Highway to Health,” host David Kemp discussed the issue of unattainable healthcare with Molecular Testing Lab’s new CEO, Eric Strafel. Kemp stated that healthcare workers have a daily goal to make a great impact in the lives of their patients, and also make significant improvements. For Strafel, he said Molecular…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Highway to Health on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

In the latest episode of “Highway to Health,” host David Kemp discussed the issue of unattainable healthcare with Molecular Testing Lab’s new CEO, Eric Strafel. Kemp stated that healthcare workers have a daily goal to make a great impact in the lives of their patients, and also make significant improvements. For Strafel, he said Molecular Testing Lab is closing a gap in access with at-home services. A lot of factors play a role in how people in certain areas of the country access personal healthcare, and these differing components have an effect on that. 

“When you look at the social determinants to health, it’s the environment, physical, social, and access to care that people have in their community, which varies widely,” said Strafel. Offering at-home service to patients, particularly to patients in underserved and rural areas, makes it a great solution to providing care and creating accessibility. 

A key solution for this is directly looking to the areas and demographics of where and who is not getting good access to healthcare. Not only does this service bring healthcare to homes where some patients might have certain fears like white-coat syndrome, or worry about stigmas in regarding to sexual health tests, it helps them get ahead of certain illnesses. “We can try to get testing to communities that have a hard time getting testing … so people can test for chronic conditions, therefore get in front of it so they can get into preventive health instead of trying to deal with an issue when it’s already too late,” said Strafel.  

Strafel agreed with Kemp that Molecular Testing Lab is disrupting many healthcare norms with their innovation. He said that testing is only a fraction of the greater solution. He said that while his company is only trying to play a small role and is more focused on forging partnerships with other organizations, he believes that healthcare’s innovation will mostly come from small and mid-sized companies, and not from one particular major corporation. 

Highway to Health

Part of this channel

Highway to Health

Healthcare innovation conversations for executives and technology buyers.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Ambulatory surgery center volumes are projected to rise 24% over the next decade, with anesthesiology and gastroenterology shortages projected for 2027. That puts potential staffing constraints early in the growth period, so operators planning coverage may find the nearer 2027 date sets the pace.

  • 01A 24% ten-year forecast and a 9% forecast for 2023 to 2028 measure different windows; check the time frame and start year before putting either in a budget.
  • 02With about nine in ten ASCs at least partly physician-owned, a staffing gap could hit physician owners directly as clinicians and investors.

Oct 30, 2026

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea CEO Nikos Paragios said at ASTRO 2026 in Boston that vendor-agnostic AI software like ART-Plan can raise radiotherapy throughput on existing machines. A February 2025 Lancet Oncology study puts the global linac shortfall at 30%, with 36 of 181 countries owning no linac, limiting how far software alone can go.

  • 01A February 2025 Lancet Oncology study found a global median Linac Shortage Index of 130, a 30% capacity shortfall, and 36 of 181 countries with no linac at all.
  • 02Bundled adaptive systems already exist: Varian’s Ethos won FDA clearance in February 2020 and RaySearch demoed automated replanning at ASTRO, but buyers still need to validate acceptability and sign-off workflows.

Oct 29, 2026

Berg Insight expects 160 million home medical monitors in care programs by 2030

Berg Insight expects 160 million home medical monitors in care programs by 2030

Prescribed connected home medical monitors are forecast to grow from 92.7 million in 2025 to 159.7 million by 2030. Fastest growth is in diabetes, remote ECG and medication compliance, spread across many suppliers. Berg and IoT Business News argue value depends on integrating data into workflows.

  • 01159.7 million prescribed home medical monitors expected by 2030, growing at 11.5 percent annually from 92.7 million in 2025.
  • 02Sleep therapy is the largest connected segment, followed by diabetes with 19.5 million connections at end of 2025, with fastest future growth in diabetes, remote ECG and medication compliance monitoring.
  • 03Clinical value increasingly depends on integrating data across devices into workflows: vendors combine hardware, software, analytics and interoperability with existing healthcare systems.

Oct 26, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512